Neo Ethics Pharmaceuticals Private Limited
About Neo Ethics Pharmaceuticals Private Limited
Data last updated:
Neo Ethics Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 January 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1990PTC018549.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹18.36 Lakh. It is led by directors Nagasamy Krishnamurthy and Saroja Subramaniam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N01 Balajinagar Firststreet Ekkattuthangal, Chennai, Tamil Nadu, India – 600032.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.29 Lakh. For the same year it recorded a net profit of ₹3.83 Lakh (net margin 52.6%) and EBITDA of ₹3.83 Lakh (EBITDA margin 52.6%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
As per MCA filings, the company has satisfied charges of ₹2.42 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Neo Ethics Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressN01 Balajinagar Firststreet Ekkattuthangal, Chennai, Tamil Nadu, India – 600032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Neo Ethics Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neo Ethics Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neo Ethics Pharmaceuticals Private Limited, buy the company report.
Financials of Neo Ethics Pharmaceuticals Private Limited
FY 2025 filings availableNeo Ethics Pharmaceuticals Private Limited reported revenue of ₹7.29 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years. EBITDA rose 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 52.6% | ||||
| Net Profit Margin | 52.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neo Ethics Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neo Ethics Pharmaceuticals Private Limited
Neo Ethics Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagasamy Krishnamurthy Also directs: Ve Leathers India Private Limited | Director | 27 Jun 2018 | 8 Years 4 Months | Current |
| Saroja Subramaniam Also directs: Ve Leathers India Private Limited | Director | 15 Jul 1994 | 32 Years 3 Months | Current |
Peer comparison
Neo Ethics Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sathyalok Healthcare Private Limited | ₹7.31 Lakh (FY 2019) | -30.0% | Chennai, Tamil Nadu, India | |||
| Herman Galenics Pharmaceuticals Private Limited | ₹7.3 Lakh (FY 2025) | -29.0% | Chennai, Tamil Nadu, India | |||
| Neo Ethics Pharmaceuticals Private Limitedthis company | ₹7.29 Lakh (FY 2025) | ₹3.83 Lakh | 52.6% | Chennai, Tamil Nadu, India | ||
| Lapetus Pharmaceuticals Private Limited | ₹7.25 Lakh (FY 2025) | 68.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Neo Ethics Pharmaceuticals Private Limited, buy the company report.
Auditor
Neo Ethics Pharmaceuticals Private Limited is audited by N NARESH & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N NARESH & CO | FY 2019 | 011293S |
Shareholding
The shareholding of Neo Ethics Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Neo Ethics Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 May 1993 | 90316990 | The Tamilnadu Industrial Investment Corp. Ltd. | ₹2.42 Lakh | Satisfied |
To see the full charge records of Neo Ethics Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Neo Ethics Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neo Ethics Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neo Ethics Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neo Ethics Pharmaceuticals Private Limited has 3 board changes on record since 1994: 2 appointments and 1 cessation. The latest: Sankara Subramanian ceased to be Director on 30 Jun 2018.
Frequently asked questions
Neo Ethics Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 January 1990 (36+ years old) and is registered under CIN U24231TN1990PTC018549.
Neo Ethics Pharmaceuticals has 2 current directors:
- Nagasamy Krishnamurthy - Director
- Saroja Subramaniam - Director
The latest financial statements of Neo Ethics Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Neo Ethics Pharmaceuticals is U24231TN1990PTC018549. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neo Ethics Pharmaceuticals was incorporated on 04 January 1990, making it 36+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Neo Ethics Pharmaceuticals by revenue are Sathyalok Healthcare Private Limited, Herman Galenics Pharmaceuticals Private Limited, Lapetus Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sankara Subramanian ceased to be Director on 30 Jun 2018. Nagasamy Krishnamurthy was appointed as Director on 27 Jun 2018. Saroja Subramaniam was appointed as Director on 15 Jul 1994.
The registered office of Neo Ethics Pharmaceuticals is at N01 Balajinagar Firststreet Ekkattuthangal, Chennai, Tamil Nadu, India – 600032.
Neo Ethics Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Neo Ethics Pharmaceuticals has no open charges and satisfied charges of ₹2.42 Lakh as per latest MCA filings.
The compliance status of Neo Ethics Pharmaceuticals is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
